Cargando…

Cost and cost-effectiveness of four different SARS-CoV-2 active surveillance strategies: evidence from a randomised control trial in Germany

INTRODUCTION: The COVID-19 pandemic has entered its third year and continues to affect most countries worldwide. Active surveillance, i.e. testing individuals irrespective of symptoms, presents a promising strategy to accurately measure the prevalence of SARS-CoV-2. We aimed to identify the most cos...

Descripción completa

Detalles Bibliográficos
Autores principales:	Nguyen, Hoa Thi, Denkinger, Claudia M., Brenner, Stephan, Koeppel, Lisa, Brugnara, Lucia, Burk, Robin, Knop, Michael, Bärnighausen, Till, Deckert, Andreas, De Allegri, Manuela
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer Berlin Heidelberg 2023
Materias:	Original Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9850332/ https://www.ncbi.nlm.nih.gov/pubmed/36656403 http://dx.doi.org/10.1007/s10198-022-01561-8

Ejemplares similares

Effectiveness and cost-effectiveness of four different strategies for SARS-CoV-2 surveillance in the general population (CoV-Surv Study): a structured summary of a study protocol for a cluster-randomised, two-factorial controlled trial
por: Deckert, Andreas, et al.
Publicado: (2021)

Effectiveness and cost-effectiveness of four different strategies for SARS-CoV-2 surveillance in the general population (CoV-Surv Study): study protocol for a two-factorial randomized controlled multi-arm trial with cluster sampling
por: Deckert, Andreas, et al.
Publicado: (2021)

Comparison of Four Active SARS-CoV-2 Surveillance Strategies in Representative Population Sample Points: Two-Factor Factorial Randomized Controlled Trial
por: Deckert, Andreas, et al.
Publicado: (2023)

The economic cost of implementing antigen-based rapid diagnostic tests for COVID-19 screening in high-risk transmission settings: evidence from Germany
por: Hurtado, Alfonso Valenzuela, et al.
Publicado: (2022)

From disgusting and complicated to simple and brilliant: Implementation perspectives and lessons learned from users and rejectors of mail-in SARS-CoV-2 gargle tests
por: Röhr, Freda, et al.
Publicado: (2023)

Kopfkino: Phases of quarantine among asymptomatic SARS-COV-2 carriers in Germany
por: Uellner, Ferdinand, et al.
Publicado: (2022)

Scalable RT‐LAMP‐based SARS‐CoV‐2 testing for infection surveillance with applications in pandemic preparedness
por: Lou, Dan, et al.
Publicado: (2023)

The cost-effectiveness of using results-based financing to reduce maternal and perinatal mortality in Malawi
por: Chinkhumba, Jobiba, et al.
Publicado: (2020)

Population-Level Impact of Omitting Axillary Lymph Node Dissection in Early Breast Cancer Women: Evidence from an Economic Evaluation in Germany
por: Nguyen, Hoa Thi, et al.
Publicado: (2022)

Household costs and time to seek care for pregnancy related complications: The role of results-based financing
por: Chinkhumba, Jobiba, et al.
Publicado: (2017)

Design of an impact evaluation using a mixed methods model – an explanatory assessment of the effects of results-based financing mechanisms on maternal healthcare services in Malawi
por: Brenner, Stephan, et al.
Publicado: (2014)

The intangible costs of overweight and obesity in Germany
por: Meng, Fan, et al.
Publicado: (2023)

The societal cost of treatment-seeking patients with borderline personality disorder in Germany
por: Wagner, Till, et al.
Publicado: (2021)

Potential cost-effectiveness and benefit-cost ratios of adult pneumococcal vaccination in Germany
por: Kuhlmann, Alexander, et al.
Publicado: (2012)

Costs and cost-effectiveness of HIV early infant diagnosis in low- and middle-income countries: a scoping review
por: Elsbernd, Kira, et al.
Publicado: (2022)

How much does it cost to combine supply-side and demand-side RBF approaches in a single intervention? Full cost analysis of the Results Based Financing for Maternal and Newborn Health Initiative in Malawi
por: Torbica, Aleksandra, et al.
Publicado: (2022)

Cost-effectiveness of adalimumab for rheumatoid arthritis in Germany
por: Gissel, C., et al.
Publicado: (2016)

Cost-effectiveness of human papillomavirus vaccination in Germany
por: Damm, Oliver, et al.
Publicado: (2017)

Costs of patients with chronic kidney disease in Germany
por: Gandjour, Afschin, et al.
Publicado: (2020)

Estimation of Tinnitus-Related Socioeconomic Costs in Germany
por: Tziridis, Konstantin, et al.
Publicado: (2022)

To What Extent Do Free Healthcare Policies and Performance-Based Financing Reduce Out-of-Pocket Expenditures for Outpatient services? Evidence From a Quasi-experimental Study in Burkina Faso
por: Aye, Thit Thit, et al.
Publicado: (2022)

The social cost of contacts: Theory and evidence for the first wave of the COVID-19 pandemic in Germany
por: Quaas, Martin F., et al.
Publicado: (2021)

Tuberculosis and poverty: the contribution of patient costs in sub-Saharan Africa – a systematic review
por: Barter, Devra M, et al.
Publicado: (2012)

Simulation of pooled-sample analysis strategies for COVID-19 mass testing
por: Deckert, Andreas, et al.
Publicado: (2020)

Change in the direct cost of treatment for children and adolescents with hyperkinetic disorder in Germany over a period of four years
por: Wehmeier, Peter M, et al.
Publicado: (2009)

The cost and cost-effectiveness of rapid testing strategies for yaws diagnosis and surveillance
por: Fitzpatrick, Christopher, et al.
Publicado: (2017)

Direct costs of hypertensive patients admitted to hospital in Vietnam– a bottom-up micro-costing analysis
por: Nguyen, Thi-Phuong-Lan, et al.
Publicado: (2014)

Health care cost containment in the Federal Republic of Germany
por: Schneider, Markus
Publicado: (1991)

Cost per responder of TNF-α therapies in Germany
por: Gissel, Christian, et al.
Publicado: (2013)

The high cost of half-hearted breastfeeding promotion in Germany
por: Rouw, Elien, et al.
Publicado: (2015)

Treatment Costs of Colorectal Cancer by Sex and Age: Population-Based Study on Health Insurance Data from Germany
por: Heisser, Thomas, et al.
Publicado: (2022)

Maintenance versus replacement of medical equipment: a cost-minimization analysis among district hospitals in Nepal
por: Hillebrecht, Michael, et al.
Publicado: (2022)

Community preferences for a social health insurance benefit package: an exploratory study among the uninsured in Vietnam
por: Nguyen, Hoa Thi, et al.
Publicado: (2017)

Cost-Effectiveness of Treating Hepatitis C with Sofosbuvir/Ledipasvir in Germany
por: Stahmeyer, Jona T., et al.
Publicado: (2017)

Cost of illness of non-multidrug-resistant tuberculosis in Germany: an update
por: Diel, Roland, et al.
Publicado: (2020)

Direct cost of cochlear implants in Germany – a strategic simulation
por: Thum, Christin, et al.
Publicado: (2022)

A Model-Based Estimate of the Cost-Effectiveness Threshold in Germany
por: Gandjour, Afschin
Publicado: (2023)

Cost-Effectiveness of Lipid-Lowering Therapies for Cardiovascular Prevention in Germany
por: Michaeli, Daniel Tobias, et al.
Publicado: (2022)

Surveillance following breast cancer: is it cost-effective?
por: Ternent, L, et al.
Publicado: (2010)

Unforeseen Costs of Cutting Mosquito Surveillance Budgets
por: Vazquez-Prokopec, Gonzalo M., et al.
Publicado: (2010)

Cannot write session to /tmp/vufind_sessions/sess_vukkrds756rt8fb15s8c1afk4d